Toronto Machine Learning Series (TMLS)
AI-Aided Design of Novel Inhibitors Against SARS-CoV-2
Explore AI-driven drug design for SARS-CoV-2, focusing on 3CLpro inhibitors. Learn about deep Q-learning networks, fragment-based design, and structure-based optimization for developing potential lead compounds.